Scandinavian Mycosis Fungoides Trial
The Scandinavian Mycosis Fungoides Group was founded in 1974. It is a multi-center study group with the aim of evaluating new treatment modalities as well as establishing diagnostic criteria and prognostic factors in the cutaneous T cell lymphoma mycosis fungoides (MF). Eighteen dermatologic departments in Denmark, Norway, and Sweden participate in this study. By January 1981 a total of 169 patients have been registered by the group and have received treatment according to one or more treatment protocols accepted by the participating departments.
KeywordsLymphoma Methotrexate Cyclophosphamide Prednisone Prednisolone
Unable to display preview. Download preview PDF.
- Molin L, Thomsen K, Volden G, Groth O, Zachariae H, Grunnet E, Hillström L, Lidén S, Knudsen EA, Roupe G, Schmidt H, Brehmer-Andersson E, Eeg Larsen T, Hou-Jensen K, Søgaard H (1979 c) Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction. Acta Derm Venereol 59:64–68PubMedGoogle Scholar